InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Aura Biosciences, Inc.

AURA Clue Score20
United States Fiscal year ends December CIK 0001501796 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
Amy Elazzouzi
18 Aug 2025
Senior Vice President, Finance
Sold after exercise
7,722
$6.70
$51.74K
los Pinos Elisabet de
18 Oct 2024
See Remarks
Sold after exercise
24,992
$12.04
$300.84K
Julie B Feder
18 Oct 2024
Chief Financial Officer
Sold after exercise
25,131
$12.03
$302.36K
Julie B Feder
6 Nov 2023
Chief Financial Officer
Sold after exercise
3,900
$12.07
$47.05K
los Pinos Elisabet de
6 Nov 2023
See Remarks
Sold after exercise
7,449
$12.03
$89.61K
Show all 71 transactions →

What was left out

Form 4 filings counted 112
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 8,755,291
Sales filed before the plan box existed 4
History held since 29 Oct 2021